Cell Therapeutics (CTIC) Posts Narrower Q1 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
EPS Growth %: +100.0%
Financial Fact:
Total operating expenses: 33.1M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +100.0%
Financial Fact:
Total operating expenses: 33.1M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- 'A moment of truth' for Tesla and Musk is here - Wedbush
- Warren Buffet's Berkshire stock target raised at UBS into earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
